BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 27270540)

  • 21. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
    Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
    J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
    Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
    J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testicular doses in image-guided radiotherapy of prostate cancer.
    Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
    Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
    Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT/VMAT.
    Hammers JE; Pirozzi S; Lindsay D; Kaidar-Person O; Tan X; Chen RC; Das SK; Mavroidis P
    J Appl Clin Med Phys; 2020 Feb; 21(2):14-25. PubMed ID: 32058663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
    Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
    Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
    Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
    J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy.
    Bell LJ; Cox J; Eade T; Rinks M; Herschtal A; Kneebone A
    Radiat Oncol; 2015 Jul; 10():151. PubMed ID: 26209446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities.
    Lin MH; Price RA; Li J; Kang S; Li J; Ma CM
    Phys Med Biol; 2013 Nov; 58(22):8179-96. PubMed ID: 24200917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of aSi-kVCBCT for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy.
    Gandhi A; Vellaiyan S; Subramanian S; Swamy ST; Subramanian K; Ayyalusamy A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):229-234. PubMed ID: 30678437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.
    Ariyaratne H; Chesham H; Pettingell J; Alonzi R
    Radiother Oncol; 2016 Oct; 121(1):103-108. PubMed ID: 27576431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.